RNF14P2

Across TCGA pan-cancer cohorts, RNF14P2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNF14P2’s most consistent transcriptional readouts.

The strongest signal is observed in cholangiocarcinoma (CHOL), where RNF14P2 RNA is repressed in tumor relative to normal tissue. In most cancer types RNF14P2 is over-expressed in tumor, although a few such as CHOL and KIRP show the opposite, repressed pattern.

CHOL and KIRP are the cancer types where RNF14P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNF14P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CHOL	All	All	−0.278	.037	1	view →
KIRP	Male	All	−0.101	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RNF14P2–CHOL

Open the CHOL breakdown →